Related references
Note: Only part of the references are listed.How to Make More Published Research True
John P. A. Ioannidis
PLOS MEDICINE (2014)
The role of NF-κB in SAA-induced peroxisome proliferator-activated receptor γ activation
Hongzhe Li et al.
ATHEROSCLEROSIS (2013)
Dyslipidemia and oxidative stress in sarcoidosis patients
Jasmina Ivanisevic et al.
CLINICAL BIOCHEMISTRY (2012)
Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome
Paul Jan Willem Herman Kappelle et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders
Georgios Daniil et al.
CLINICA CHIMICA ACTA (2011)
Analysis of serum amyloid A in sarcoidosis patients
E. Bargagli et al.
RESPIRATORY MEDICINE (2011)
Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2
Edward S. Chen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Comparative Evaluation of Serum Markers in Pulmonary Sarcoidosis
Seigo Miyoshi et al.
CHEST (2010)
HDL 2 Particles are associated with hyperglycaemia, lower PON1 activity and oxidative stress in type 2 diabetes mellitus patients
Aleksandra Stefanovic et al.
CLINICAL BIOCHEMISTRY (2010)
Paraoxonase: A multifaceted biomolecule
Binita Goswami et al.
CLINICA CHIMICA ACTA (2009)
Systemic oxidative stress in patients with pulmonary sarcoidosis
Angela Koutsokera et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients
Jelena Kotur-Stevuljevic et al.
CLINICAL BIOCHEMISTRY (2008)
Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease
Daryoush Hamidi Alamdari et al.
CLINICAL BIOCHEMISTRY (2008)
Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis
H. Uzun et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
Jelena Kotur-Stevuljevic et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes
Chang Yeop Han et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Oxidant and antioxidant balance in the airways and airway diseases
I Rahman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
A new automated colorimetric method for measuring total oxidant status
O Erel
CLINICAL BIOCHEMISTRY (2005)
Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases
AG Lenz et al.
RESPIRATORY MEDICINE (2004)
Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis
S Rothkrantz-Kos et al.
CLINICAL CHEMISTRY (2003)
Serum paraoxonase activity decreases in rheumatoid arthritis
N Tanimoto et al.
LIFE SCIENCES (2003)
Serum amyloid A and high-density lipoprotein cholesterol:: serum markers of inflammation in sarcoidosis and other systemic disorders
A Salazar et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis
A Salazar et al.
ATHEROSCLEROSIS (2000)
Share Paper
